BioVariance Blog

Antibody study gives way to the telomere length study

We would like to take this opportunity to thank the volunteers for their willingness to support Ms. Schraml in her doctoral thesis. Due to known difficulties and the long outdated topic, the antibody study will

New Categorization of a Cancer Indication

The Goal – Advance Personalized Medicine BioVariance GmbH focuses together with a global player from the pharmaceutical industry on advancing research in personalized medicine. Due to the outstanding cooperation and the excellent expertise of both

Effective Data Processing with BioCore Studio

Due to the rapid development of bioanalytical high-throughput technologies, such as NGS or HPLC/UPLC-MS, it became easy to generate complex data in record time. To answer research questions adequately, it is of utmost importance to

Validation of PCR oligos for SARS-CoV-2 test

The global SARS-CoV-2 pandemic is an emerging, rapidly evolving situation. Therefore, increasing the test capacity to detect a virus infection is of utmost importance. BioVariance GmbH helped to fortify the regulatory submission proposal of a